Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetic Patients Type 1 and 2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01474161
What this trial is testing

Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505

Who this might be right for
Type 2 DiabetesDiabetes Mellitus, Type 2Metabolic Diseases+3 more
Genfit 96
Not applicableUnknownNCT02887625
What this trial is testing

Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

Who this might be right for
Type 2 Diabetes
Dr. Muhammad Abdulghani 410
Testing effectiveness (Phase 2)Study completedNCT00566358
What this trial is testing

Surgical Treatment of Non-obese Type 2 Diabetic Patients With Duodenal Exclusion

Who this might be right for
Diabetes Mellitus, Type 2
University of Campinas, Brazil 18
Not applicableStudy completedNCT01646047
What this trial is testing

Diabetes Visual Function Supplement Study

Who this might be right for
Diabetes Mellitus - Type 1Diabetes Mellitus - Type 2Non-proliferative Diabetic Retinopathy
ZeaVision, LLC 70
Testing effectiveness (Phase 2)Study completedNCT05514548
What this trial is testing

Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Inversago Pharma Inc. 265
Not applicableStudy completedNCT01857076
What this trial is testing

Surgical Treatment in Diabetic Patients With Grade 1 Obesity

Who this might be right for
ObesityType 2 Diabetes Mellitus
Hospital Sirio-Libanes 75
Post-approval studies (Phase 4)Study completedNCT02299050
What this trial is testing

Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue Therapy

Who this might be right for
Type 2 Diabetes
The University of Texas Health Science Center at San Antonio 23
Not applicableStudy completedNCT07555327
What this trial is testing

Clinical Observation of Renal Function Reactivation Following a GRAS-Based Protocol in Patients With Chronic Kidney Disease and Long-Term Renal Arrest.

Who this might be right for
End-Stage Renal Disease (ESRD) Chronic Kidney Disease, Stage 5 Renal Regeneration Anuria Diabetic NephropathyAnuriaEnd-Stage Renal Disease (ESRD)+6 more
Amar h Zireg 8
Post-approval studies (Phase 4)Study completedNCT00153023
What this trial is testing

1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy

Who this might be right for
Diabetic NephropathiesHypertension
Boehringer Ingelheim 885
Not applicableStudy completedNCT07386613
What this trial is testing

Feasibility of Home Monitoring of Visual Function in DR

Who this might be right for
Diabetes (DM)Diabetes ComplicationDiabetes (Insulin-requiring, Type 1 or Type 2)+4 more
Queen's University, Belfast 55
Testing effectiveness (Phase 2)Study completedNCT00375960
What this trial is testing

A Research Study of V3381 for the Treatment of Diabetic Peripheral Neuropathic Pain

Who this might be right for
PainDiabetic Neuropathies
Vernalis (R&D) Ltd 50
Large-scale testing (Phase 3)Study completedNCT00044408
What this trial is testing

Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes

Who this might be right for
Diabetic NeuropathiesDiabetes Mellitus, Insulin-DependentDiabetes Mellitus, Non-Insulin-Dependent
Chromaderm, Inc. 200
Not applicableStudy completedNCT01487408
What this trial is testing

Special Survey for Type 1 or Type 2 Diabetic Patients

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,463
Not applicableUnknownNCT06623708
What this trial is testing

SMARTCLOTH. Design, Implementation and Study of the Effectiveness and Usability of a Digital Tablecloth for Self-management of Diet in Diabetic Patients.

Who this might be right for
Diabetes Mellitus Type 2Diabetes Mellitus Type 1
Maimónides Biomedical Research Institute of Córdoba 90
Not applicableStudy completedNCT00839150
What this trial is testing

Retinal Function in Diabetic Patients Without Retinopathy

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Assistance Publique - Hôpitaux de Paris 56
Not applicableLooking for participantsNCT01055093
What this trial is testing

Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
German Diabetes Center 2,000
Not applicableEnded earlyNCT04699864
What this trial is testing

Evaluation of NeoRetina Artificial Intelligence Algorithm for the Screening of Diabetic Retinopathy at the CHUM

Who this might be right for
Diabetic RetinopathyDiabetic Macular EdemaDiabetic Maculopathy
Centre hospitalier de l'Université de Montréal (CHUM) 24
Large-scale testing (Phase 3)Ended earlyNCT00391196
What this trial is testing

A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients

Who this might be right for
Obesity
Pfizer 975
Testing effectiveness (Phase 2)WithdrawnNCT04661917
What this trial is testing

A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.

Who this might be right for
Chronic Kidney DiseaseDiabetic Kidney Disease
Bayer
Not applicableStudy completedNCT01460446
What this trial is testing

ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)?

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Hoffmann-La Roche 218
Next Page